Scientists hunt for hidden clues to help women with low egg reserve
NCT ID NCT06617988
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study examined 80 women undergoing IVF to see if a protein called SIRT3 and certain metabolic markers differ among subtypes of poor ovarian response. Researchers collected discarded fluid and cells from egg retrieval to analyze these differences and link them to IVF success. The study is purely observational, meaning no treatment was given—it aims to uncover biological targets for future research.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help identify biological markers to better classify poor ovarian response and potentially guide future fertility treatments.
- What could go wrong
- This is a small, completed observational study (80 participants) that does not test any treatment. Findings may not lead to direct clinical changes without further research.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
80 people
The number who actually took part.
- Started
-
Nov 2024
- Finished
-
Sep 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
The study cohort will prospectively enroll women undergoing in vitro fertilization and embryo transfer (IVF-ET) treatment at the Department of Reproduction and Genetics, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, from October 2024 to January 2025. This cohort will be stratified into four study groups based on the following criteria in equal proportions. All participants will receive the standard operation protocol for In vitro fertilization and embryo transfer.
- Ages
-
20 to 45 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 1\. Women who are married and aged between 20 to 45 years, diagnosed with infertility; * 2\. Individuals undergoing their first or second cycle of in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), with a scheduled fresh embryo transfer; * 3\. Participants must fulfill the diagnostic criteria corresponding to one of the following prognostic categories as determined by the clinician: Normal prognosis, unexpected poor prognosis, poor prognosis of advanced maternal age, or expected poor prognosis. Exclusion Criteria: * 1\. A body mass index (BMI) of ≥ 35 kg/m²; * 2\. Participation in cycles involving pre-implantation genetic testing or diagnosis of embryos; * 3\. Involvement in cycles utilizing frozen gametes; * 4\. Engagement in cycles that employ donor-derived oocytes; * 5\. Participation in in vitro maturation cycles; * 6.The presence of uterine cavity or endometrial abnormalities, including but not limited to fibroids, endometrial polyps, malformations, adenomyomas, endometritis, endometrial thinning, hydrosalpinx, uterine infections; * 7.The existence of contraindications to assisted reproductive technology or pregnancy, such as uncontrolled liver or kidney dysfunction, diabetes mellitus (with glycated hemoglobin ≤ 7% and fasting blood glucose \< 10 mmol/L), hypertension, thyroid disorders, asymptomatic cardiac conditions, moderate-to-severe anemia, malignancies, a history of thromboembolism or thrombosis, severe mental health disorders, acute infections of the urinary and reproductive systems, sexually transmitted infections, and detrimental lifestyle factors including substance abuse. Additionally, exposure to teratogenic levels of radiation, toxins, or medications (such as prednisone, other hormones, adrenaline, antibiotics, or medications for hypertension, cardiovascular issues, or antiviral treatment) during surgical procedures, as well as any physical conditions rendering pregnancy inadvisable, are also considered disqualifying factors.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Poor ovarian response are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Jinan, Shandong, 250011, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Three ways to trigger ovulation: which yields more mature eggs in Low-Reserve IVF?
- Could a blood treatment revive Low-Ovarian-Response? new study investigates
- Could a shot of your own cells boost fertility? new trial aims to find out.
- Can a blood injection boost fertility? new trial tests PRP for poor ovarian response